Physician, scientist, educator, head of Psychiatry at @WUSTLmed. Director of Healthy Mind Lab, https://xitter.cf/t.co/el5ZDan0a0
St Louis
Joined January 2021
- Tweets152
- Following103
- Followers668
- Likes397
Glad to publish a review of geroscience and mental health with Breno Diniz and colleagues in @AmJGeriPsych.
sciencedirect.com/science/ar…
Mental disorders accelerate aging and lead to premature mortality and dementia. Now we have pathways for intervention.
Our second COVID treatment study available to read.
Negative/failed study, but great example of a fully-remote trial.
academic.oup.com/ofid/articl…
Published the (negative) results of our second fluvoxamine study for COVID.
pubmed.ncbi.nlm.nih.gov/3762…
We couldn't replicate our initial 2020 JAMA paper - even while other researchers did. But I'm proud of the team for the study (doing a fully remote clinical trial during COVID!).
Everyone is interested in psychedelics for mental illness - but how do they work? New study out of WashU psychiatry provides answers.
This quoted post is unavailable.
Great to see more evidence of fluvoxamine's efficacy for COVID-19
🔥 TOGETHER RCT 🔥
Treatment with oral fluvoxamine plus inhaled budesonide among high-risk outpatients with early COVID-19 reduced the incidence of severe disease requiring advanced care #IDTwitter
acpjournals.org/doi/10.7326/…
ALT TOGETHER RCT
I'm excited to announce that #washu psychiatry has matched 14 EXCEPTIONAL people who will make a huge positive impact in mental health.
To each of you - it was great to meet you during the interviews, I look forward to seeing you again in June.
Exciting #childpsychiatry talk at #washu by Dr Kirsten Gilbert. Too much control = risk for psychiatric disorders (anxiety, depression, eating disorders). Her treatment research should help!
Calling all clinical trialists! This request by #NCATS for #decentralizedtrials could be a game-changer for clinical medicine. I can't overstate how much better this could be for developing, testing, personalizing, and optimizing treatments.
How to translate neuroscience advances into new treatments for depression, anxiety, psychosis? Adam Kepecs @KepecsLab uses novel circuitry-based phenotypes to translate from mouse to human. Great talk Adam!
#Anxiety disorders in older adults are common, impairing, and treatable. That's the point of a new article by @paula_span in @nytimes: nytimes.com/2023/02/26/healt…
Thanks to US Preventive Services Task Force for advocating for research on this!
Congratulations to Simone Bernstein, outstanding resident at @washu and Laughlin Fellow for the American College of Psychiatrists!
Sometimes your medically hospitalized patient has demoralization, not depression! So don't start medication and contribute to polypharmacy!
That's the take-home from a great talk today at #washu psychiatry by outstanding resident Can Misel Kilciksiz MD.
Enjoyed talk at #washu psychiatry today -- the renowned Dr Joan Luby told us how to overcome the cycle of poverty and adversity in child development. #nobelprize committee, are you listening?
#borderlinepersonalitydisorder -- untreatable? Not so fast!
At #WashU Department of Psychiatry, Diana Whalen and her team developed an elegant, data-based conceptual model for the development of BPD -- time to invest in more research, for treatment and prevention!
Bravo Diana!
For a GREAT summary of our recent findings in #JAMA showing no cognitive benefit in older adults from #mindfulness training or #exercise, here is a Medscape article from @fperrywilson: medscape.com/viewarticle/985…
Our new study, published in JAMA today:
#exercise and #mindfulness do not boost cognitive function in older adults.
jamanetwork.com/journals/jam…
Controversial? Probably. Disappointing? Maybe. But my lab will continue to test new ways to help older adults have a Healthy Mind.
Thanks to #NIA , #NCCIH, #OBSSR, and @McKnightBrain1 for funding this project. Funding #clinicaltrials is how medical science moves forward.